Impact of Pharmaceuticals on the Individual Wastewater Treatment System
Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as wel...
Ausführliche Beschreibung
Autor*in: |
Małgorzata Helena Makowska [verfasserIn] Marcin Spychała [verfasserIn] Katarzyna Gajewska [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2024 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Journal of Ecological Engineering - Polish Society of Ecological Engineering (PTIE), 2014, 25(2024), 2, Seite 257-266 |
---|---|
Übergeordnetes Werk: |
volume:25 ; year:2024 ; number:2 ; pages:257-266 |
Links: |
---|
DOI / URN: |
10.12911/22998993/176945 |
---|
Katalog-ID: |
DOAJ097958417 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ097958417 | ||
003 | DE-627 | ||
005 | 20240413201556.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240413s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.12911/22998993/176945 |2 doi | |
035 | |a (DE-627)DOAJ097958417 | ||
035 | |a (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a TD1-1066 | |
050 | 0 | |a GE1-350 | |
100 | 0 | |a Małgorzata Helena Makowska |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of Pharmaceuticals on the Individual Wastewater Treatment System |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. | ||
650 | 4 | |a wastewater treatment | |
650 | 4 | |a small treatment plants | |
650 | 4 | |a activated sludge | |
650 | 4 | |a pharmaceuticals | |
653 | 0 | |a Environmental technology. Sanitary engineering | |
653 | 0 | |a Environmental sciences | |
700 | 0 | |a Marcin Spychała |e verfasserin |4 aut | |
700 | 0 | |a Katarzyna Gajewska |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Journal of Ecological Engineering |d Polish Society of Ecological Engineering (PTIE), 2014 |g 25(2024), 2, Seite 257-266 |w (DE-627)822335905 |w (DE-600)2818368-X |x 22998993 |7 nnns |
773 | 1 | 8 | |g volume:25 |g year:2024 |g number:2 |g pages:257-266 |
856 | 4 | 0 | |u https://doi.org/10.12911/22998993/176945 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 |z kostenfrei |
856 | 4 | 0 | |u http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2299-8993 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_370 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4335 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 25 |j 2024 |e 2 |h 257-266 |
author_variant |
m h m mhm m s ms k g kg |
---|---|
matchkey_str |
article:22998993:2024----::matfhraetcloteniiulatw |
hierarchy_sort_str |
2024 |
callnumber-subject-code |
TD |
publishDate |
2024 |
allfields |
10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266 |
spelling |
10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266 |
allfields_unstemmed |
10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266 |
allfieldsGer |
10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266 |
allfieldsSound |
10.12911/22998993/176945 doi (DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 DE-627 ger DE-627 rakwb eng TD1-1066 GE1-350 Małgorzata Helena Makowska verfasserin aut Impact of Pharmaceuticals on the Individual Wastewater Treatment System 2024 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences Marcin Spychała verfasserin aut Katarzyna Gajewska verfasserin aut In Journal of Ecological Engineering Polish Society of Ecological Engineering (PTIE), 2014 25(2024), 2, Seite 257-266 (DE-627)822335905 (DE-600)2818368-X 22998993 nnns volume:25 year:2024 number:2 pages:257-266 https://doi.org/10.12911/22998993/176945 kostenfrei https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 kostenfrei http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html kostenfrei https://doaj.org/toc/2299-8993 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 25 2024 2 257-266 |
language |
English |
source |
In Journal of Ecological Engineering 25(2024), 2, Seite 257-266 volume:25 year:2024 number:2 pages:257-266 |
sourceStr |
In Journal of Ecological Engineering 25(2024), 2, Seite 257-266 volume:25 year:2024 number:2 pages:257-266 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
wastewater treatment small treatment plants activated sludge pharmaceuticals Environmental technology. Sanitary engineering Environmental sciences |
isfreeaccess_bool |
true |
container_title |
Journal of Ecological Engineering |
authorswithroles_txt_mv |
Małgorzata Helena Makowska @@aut@@ Marcin Spychała @@aut@@ Katarzyna Gajewska @@aut@@ |
publishDateDaySort_date |
2024-01-01T00:00:00Z |
hierarchy_top_id |
822335905 |
id |
DOAJ097958417 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ097958417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413201556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.12911/22998993/176945</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ097958417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TD1-1066</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">GE1-350</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Małgorzata Helena Makowska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of Pharmaceuticals on the Individual Wastewater Treatment System</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">wastewater treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">small treatment plants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">activated sludge</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pharmaceuticals</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental technology. Sanitary engineering</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental sciences</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marcin Spychała</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katarzyna Gajewska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Ecological Engineering</subfield><subfield code="d">Polish Society of Ecological Engineering (PTIE), 2014</subfield><subfield code="g">25(2024), 2, Seite 257-266</subfield><subfield code="w">(DE-627)822335905</subfield><subfield code="w">(DE-600)2818368-X</subfield><subfield code="x">22998993</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:257-266</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.12911/22998993/176945</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2299-8993</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2024</subfield><subfield code="e">2</subfield><subfield code="h">257-266</subfield></datafield></record></collection>
|
callnumber-first |
T - Technology |
author |
Małgorzata Helena Makowska |
spellingShingle |
Małgorzata Helena Makowska misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences Impact of Pharmaceuticals on the Individual Wastewater Treatment System |
authorStr |
Małgorzata Helena Makowska |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)822335905 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
TD1-1066 |
illustrated |
Not Illustrated |
issn |
22998993 |
topic_title |
TD1-1066 GE1-350 Impact of Pharmaceuticals on the Individual Wastewater Treatment System wastewater treatment small treatment plants activated sludge pharmaceuticals |
topic |
misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences |
topic_unstemmed |
misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences |
topic_browse |
misc TD1-1066 misc GE1-350 misc wastewater treatment misc small treatment plants misc activated sludge misc pharmaceuticals misc Environmental technology. Sanitary engineering misc Environmental sciences |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Journal of Ecological Engineering |
hierarchy_parent_id |
822335905 |
hierarchy_top_title |
Journal of Ecological Engineering |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)822335905 (DE-600)2818368-X |
title |
Impact of Pharmaceuticals on the Individual Wastewater Treatment System |
ctrlnum |
(DE-627)DOAJ097958417 (DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483 |
title_full |
Impact of Pharmaceuticals on the Individual Wastewater Treatment System |
author_sort |
Małgorzata Helena Makowska |
journal |
Journal of Ecological Engineering |
journalStr |
Journal of Ecological Engineering |
callnumber-first-code |
T |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2024 |
contenttype_str_mv |
txt |
container_start_page |
257 |
author_browse |
Małgorzata Helena Makowska Marcin Spychała Katarzyna Gajewska |
container_volume |
25 |
class |
TD1-1066 GE1-350 |
format_se |
Elektronische Aufsätze |
author-letter |
Małgorzata Helena Makowska |
doi_str_mv |
10.12911/22998993/176945 |
author2-role |
verfasserin |
title_sort |
impact of pharmaceuticals on the individual wastewater treatment system |
callnumber |
TD1-1066 |
title_auth |
Impact of Pharmaceuticals on the Individual Wastewater Treatment System |
abstract |
Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. |
abstractGer |
Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. |
abstract_unstemmed |
Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4335 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
2 |
title_short |
Impact of Pharmaceuticals on the Individual Wastewater Treatment System |
url |
https://doi.org/10.12911/22998993/176945 https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483 http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html https://doaj.org/toc/2299-8993 |
remote_bool |
true |
author2 |
Marcin Spychała Katarzyna Gajewska |
author2Str |
Marcin Spychała Katarzyna Gajewska |
ppnlink |
822335905 |
callnumber-subject |
TD - Environmental Technology |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.12911/22998993/176945 |
callnumber-a |
TD1-1066 |
up_date |
2024-07-03T14:40:22.323Z |
_version_ |
1803569198342864896 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ097958417</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20240413201556.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">240413s2024 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.12911/22998993/176945</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ097958417</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ93ebc83150c44f638e9fdefdde2ac483</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">TD1-1066</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">GE1-350</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Małgorzata Helena Makowska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of Pharmaceuticals on the Individual Wastewater Treatment System</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2024</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Intensive economic development causes the risk of introducing the so-called emerging contaminants (EC) into the environment. This group of contaminants includes pharmaceuticals, including non-steroidal anti-inflammatory drugs (NSAIDs), the consumption of which is steadily increasing in Poland as well as worldwide. Such specific contaminants may also cause problems at the stage of biological treatment of wastewater, especially in individual systems that are sensitive to changes in wastewater composition. The study examined an onsite wastewater treatment system based on the activated sludge technology, to which three different pharmaceuticals were dosed in the quantities normally used in therapy. The operation of the biological reactor under these conditions was analysed by comparing contamination indicators at the inlet and outlet of the treatment plant at different doses of pharmaceuticals. It was found that the doses used did not significantly worsen the effects of wastewater treatment, except for paracetamol, which at a dose above 1000 mg/d caused a slight reduction in the efficiency of the facility. The dosed pharmaceuticals also did not deteriorate the sedimentation properties of the activated sludge. Although typical doses of pharmaceuticals do not interfere with the operation of the biological reactor, residual substances and their metabolites may be released into the environment; it is therefore reasonable to consider the introduction of an additional treatment stage to remove micropollutants from the wastewater.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">wastewater treatment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">small treatment plants</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">activated sludge</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">pharmaceuticals</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental technology. Sanitary engineering</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Environmental sciences</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Marcin Spychała</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Katarzyna Gajewska</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Ecological Engineering</subfield><subfield code="d">Polish Society of Ecological Engineering (PTIE), 2014</subfield><subfield code="g">25(2024), 2, Seite 257-266</subfield><subfield code="w">(DE-627)822335905</subfield><subfield code="w">(DE-600)2818368-X</subfield><subfield code="x">22998993</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2024</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:257-266</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.12911/22998993/176945</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/93ebc83150c44f638e9fdefdde2ac483</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.jeeng.net/Impact-of-Pharmaceuticals-on-the-Individual-Wastewater-Treatment-System,176945,0,2.html</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2299-8993</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4335</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2024</subfield><subfield code="e">2</subfield><subfield code="h">257-266</subfield></datafield></record></collection>
|
score |
7.400649 |